Skip to main content
Clinical Trials/ISRCTN46299660
ISRCTN46299660
Completed
未知

nderstanding cognition and action in Parkinson’s disease

Cambridge University Hospitals NHS Foundation Trust0 sites19 target enrollmentSeptember 3, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Parkinson's disease
Sponsor
Cambridge University Hospitals NHS Foundation Trust
Enrollment
19
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 3, 2020
End Date
April 15, 2019
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Idiopathic Parkinson’s disease
  • 2\. Hoehn and Yahr stage 1\.5–3
  • 3\. Age 45 \- 80 years
  • 4\. English speaking

Exclusion Criteria

  • 1\. Dementia (MMSE 25 or less)
  • 2\. Clinically significant current depression
  • 3\. Contraindications to MRI
  • 4\. Contraindication to atomoxetine, including:
  • 4\.1 Ischemic heart disease or cardiac rhythm abnormalities
  • 4\.2 other significant non\-ischemic cardiac disease
  • 4\.3 uncontrolled hypertension
  • 4\.4 adverse drug reactions to closely related drugs
  • 4\.5 major psychiatric disorders including mania or schizophrenia
  • 4\.6 epilepsy

Outcomes

Primary Outcomes

Not specified

Similar Trials